Literature DB >> 33610199

Severe mental illness: reassessing COVID-19 vaccine priorities.

Nayanah Siva.   

Abstract

Entities:  

Year:  2021        PMID： 33610199     DOI： 10.1016/S0140-6736(21)00429-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers-a review.

Authors:  Ebrahim Payberah; Daniel Payberah; Ashish Sarangi; Jayasudha Gude
Journal:  J Egypt Public Health Assoc       Date:  2022-01-21

2.  COVID-19 Vaccine Uptake, Acceptance, and Hesitancy Among Persons With Mental Disorders During the Second Stage of China's Nationwide Vaccine Rollout.

Authors:  Hui Huang; Xiao-Min Zhu; Peng-Wei Liang; Zhong-Ming Fang; Wei Luo; Yi-Ming Ma; Bao-Liang Zhong; Helen Fung-Kum Chiu
Journal:  Front Med (Lausanne)       Date:  2021-11-11

3.  COVID-19 Vaccination and Mental Disorders, What Has Been Accomplished and Future Direction.

Authors:  Gianluca Pandolfo; Giovanni Genovese; Fiammetta Iannuzzo; Antonio Bruno; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Brain Sci       Date:  2022-02-20

4.  Mitigating COVID-19 Risk and Vaccine Hesitancy Among Underserved African American and Latinx Individuals with Mental Illness Through Mental Health Therapist-Facilitated Discussions.

Authors:  Angela L Venegas-Murillo; Mohsen Bazargan; Stephen Grace; Sharon Cobb; Roberto Vargas; Shronda Givens; Sheila Li-Sarain; Carissa Delgado; Jeffry Villatoro; Asia Goodall; Rylan Tesimale; Sylvia Ramirez; Monica Brown; John Uyanne; Shervin Assari
Journal:  J Racial Ethn Health Disparities       Date:  2022-05-09

5.  Role of medical comorbidity in the association between psychiatric disorders and mortality among patients with COVID-19.

Authors:  Gonzalo Martínez-Alés; Eduardo Fernández-Jiménez; Roberto Mediavilla; Manuel Quintana-Díaz; Iker Louzao; Susana Cebolla; Ainoa Muñoz-Sanjosé; Carmen Bayón; Ezra S Susser; María Fe Bravo-Ortiz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-03-24       Impact factor: 4.519
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.